Endocannabinoids and 3,4-methylenedioxymethamphetamine (MDMA) interaction

Pharmacology Biochemistry and Behavior

Volumn 81, Issue 2 SPEC. ISS., 2005, Pages 407-416

  Sala, Mariaelvina ^a   Braida, Daniela ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

3,4 methylenedioxymetamine; Addiction; Cognitive deficit; CP 55,490; Endocrinological abnormalities; Hyperthermia; Natural and synthetic cannabinoids; Polydrug use; Psychopathology; Rat; Self administration; SR 141716; 9 THC

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BARBITURIC ACID; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; DIAZEPAM; ENDOCANNABINOID; NALOXONE; NEUROLEPTIC AGENT; OPIATE; PSYCHEDELIC AGENT; PSYCHOSTIMULANT AGENT; RIMONABANT; TROPISETRON;

CONFERENCE PAPER; HUMAN; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; REWARD;

EID: 20444424124     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.02.016     Document Type: Conference Paper

References (121)

1. A. Ameri The effects of cannabinoids on the brain Prog Neurobiol 58 1999 315 348
2. C.H. Ashton Pharmacology and effects of cannabis: a brief review Br J Psychiatry 178 2001 181 186
3. L.E. Baker, and M.M. Taylor Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination Pharmacol Biochem Behav 57 1997 737 748
4. L.E. Baker, J. Broadbent, E.K. Michael, P.K. Matthews, C.A. Metosh, and R.B. Saunders Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3,4-methylenedioxymethamphetamine; MDMA) Behav Pharmacol 6 1995 263 275
5. L.E. Baker, T.B. Virden, M.E. Miller, and C.L. Sullivan Time course analysis of the discriminative stimulus effects of the optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) Pharmacol Biochem Behav 58 1997 505 516
6. R.L. Balster Perception of drug effects M.A. Berkley W.C. Stebbins Comparative perception Basic mechanisms vol. 1 1990 John Wiley and Sons New York 127 154
7. R.L. Balster, and W.R. Prescott Delta 9-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication Neurosci Biobehav Rev 16 1992 55 62
8. M.G. Bankson, and B.K. Yamamoto Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release J Neurochem 91 2004 852 859
9. R.L. Barrett, J.L. Wiley, R.L. Balster, and B.R. Martin Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats Psychopharmacology 118 1995 419 424
10. P.M. Beardsley, R.L. Balster, and L.S. Harris Self-administration of methylene dioxymethamphetamine (MDMA) by rhesus monkeys Drug Alcohol Depend 18 1986 149 157
11. E.J. Bilsky, and L.D. Reid MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference Pharmacol Biochem Behav 39 1991 509 512
12. E.J. Bilsky, C.L. Hubbell, J.D. Delconte, and L.D. Reid MDMA produces a conditioned place preference and elicits ejaculation in male rats: a modulatory role for the endogenous opioids Pharmacol Biochem Behav 40 1991 443 447
13. E.J. Bilsky, M.J. Montegut, M.L. Nichols, and L.D. Reid CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences Pharmacol Biochem Behav 59 1998 215 220
14. A. Boys, S. Lenton, and K. Norcross Polydrug use at raves by a Western Australian sample Drug Alcohol Rev 16 1997 227 234
15. D. Braida, and M. Sala Role of the endocannabinoid system in MDMA intracerebral self-administration in rats Br J Pharmacol 136 2002 1089 1092
16. D. Braida, W. Virag, F. Ottonello, S. Inghilterra, E. Gori, and M. Sala A novel method for self-administering addicting drugs intracerebroventricularly in a free-choice procedure Brain Res Protoc 3 1998 135 141
17. D. Braida, S. Iosuè, S. Pegorini, and M. Sala 3,4 methylenedioxymethamphetamine-induced Conditioned Place Preference (CPP) is mediated by endocannabinoid system Pharmacol Res 51 2005 177 182
18. M.E. Bronson, W. Jiang, C.R. Clark, and J. DeRuiter Effects of designer drugs on the embryo and 1-day-old chicken Brain Res Bull 34 1994 143 150
19. N. Burns, H.J. Olverman, P.A. Kelly, and B.C. Williams Effects of ecstasy on aldosterone secretion in the rat in vivo and in vitro Endocr Res 22 1996 601 606
20. A. Calafat, K. Bohrn, M. Juan, A. Kokkevi, N. Maalsté, and F. Mendes Night life in Europe and recreative drug use 1999 Irefrea and European Commission Valencia
21. J.M. Carney, I.M. Uwaydah, and R.L. Balster Evaluation of a suspension system for intravenous self-administration of water insoluble substances in the rhesus monkey Pharmacol Biochem Behav 7 1977 357 364
22. M.I. Colado, E. O'Shea, R. Granados, B. Esteban, A.B. Martín, and A.R. Green Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4- methylenedioxymethamphetamine (MDMA or "ecstasy") administration Br J Pharmacol 126 1999 911 924
23. M.I. Colado, E. O'Shea, and A.R. Green Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function Psychopharmacology 173 2004 249 263
24. J.C. Cole, H.R. Sumnall, E. O'Shea, and C.A. Marsden Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse Psychopharmacology 166 2003 383 390
25. 1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse Behav Brain Res 118 2001 61 65
26. D. Crespi, T. Mennini, and M. Gobbi Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine Br J Pharmacol 121 1997 1735 1743
27. R.J. Croft, A.J. Mackay, A.T.D. Mills, and J.G.H. Gruzieler The relative contribution of ecstasy and cannabis to cognitive impairment Psychopharmacology 153 2001 373 379
28. H.V. Curran Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research Neuropsychobiology 42 2000 34 41
29. R.I. Dafters, R. Hoshi, and A.C. Talbot Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users Psychopharmacology 173 2004 405 410
30. J. Daumann, S. Pelz, S. Becker, F. Tuchtenhagen, and E. Gouzoulis-Mayfrank Psychological profile of abstinent recreational ecstasy (MDMA) users and significance of concomitant cannabis use Hum Psychopharmacol 16 2001 627 633
31. J. Daumann, G. Hensen, B. Thimm, M. Rezk, B. Till, and E. Gouzoulis-Mayfrank Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation Psychopharmacology 173 2004 398 404
32. L. Degenhardt, B. Barker, and L. Topp Patterns of ecstasy use in Australia: findings from a national household survey Addiction 99 2004 187 195
33. G.A. Deneau, and M.H. Seevers Pharmacological aspects of drug dependence Adv Pharmacol 55 1964 267 283
34. W.A. Devane, F.A. Dysarz, M.R. Johnson, L.S. Melvin, and A.C. Howlett Determination and characterization of a cannabinoid receptor in rat brain Mol Pharmacol 34 1988 605 613
35. O.H. Drummer, J. Gerostamoulos, H. Batziris, M. Chu, J.R. Caplehorn, and M.D. Robertson The incidence of drugs in drivers killed in Australian road traffic crashes Forensic Sci Int 134 2003 154 162
36. I. Escobedo, E. O'shea, L. Orio, V. Sanchez, M. Segura, and R. de la Torre A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice Br J Pharmacol 144 2005 231 241
37. ESPAD The 1999 alcohol and other drug use among students in 30 European countries, Swedish council for information on alcohol and other drugs (CAN) 2000 The Pompidou Group of the Council of Europe
38. W.E. Fantegrossi, T. Ullrich, K.C. Rice, J.H. Woods, and G. Winger 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement Psychopharmacology 161 2002 356 364
39. M. Farrell, S. Howes, C. Taylor, G. Lewis, R. Jenkins, and P. Bebbington Substance misuse and psychiatric comorbidity: an overview of the OPCS national psychiatric morbidity survey Addict Behav 23 1998 909 918
40. 1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats Behav Brain Res 104 1999 141 146
41. 1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics Biochem Pharmacol 53 1997 1919 1927
42. K.C. Fone, S.R. Beckett, I.A. Topham, J. Swettenham, M. Ball, and L. Maddocks Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity Psychopharmacology 159 2002 437 444
43. M. Forsling, J.K. Fallon, A.T. Kicman, A.J. Hutt, D.A. Cowan, and J.A. Henry Arginine vasopressin release in response to the administration of 3,4-methylenedioxymethamphetamine ("ecstasy"): is metabolism a contributory factor? J Pharm Pharmacol 53 2001 1357 1363
44. M.L. Forsling, J.K. Fallon, D. Shah, G.S. Tilbrook, D.A. Cowan, and A.T. Kicman The effect of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus Br J Pharmacol 135 2002 649 656
45. H.C. Fox, A. McLean, J.J. Turner, A.C. Parrott, R. Rogers, and B.J. Sahakian Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users Psychopharmacology 16 2002 203 214
46. A. Gamma, E. Frei, D. Lehmann, R.D. Pascual-Marqui, D. Hell, and F.X. Vollenweider Mood state and brain electric activity in ecstasy users Neuroreport 11 2000 157 162
47. E.L. Gardner, and S.R. Vorel Cannabinoid transmission and reward-related events Neurobiol Dis 5 1998 502 533
48. E. Gouzoulis-Mayfrank, J. Daumann, F. Tuchtenhagen, S. Pelz, S. Becker, and H.J. Kunert Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) J Neurol Neurosurg Psychiatry 68 2000 719 725
49. E. Gouzoulis-Mayfrank, S. Becker, S. Pelz, F. Tuchtenhagen, and J. Daumann Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis? J Biol Psychiatry 51 2002 766 769
50. A.R. Green, A.O. Mechan, J.M. Elliott, E. O'shea, and M.I. Colado The pharmacology and clinical pharmacology of 3,4 methylenedyoxymethamphetamine (MDMA, "Ecstasy") Pharmacol Rev 55 2003 463 508
51. A.R. Green, E. O'shea, and M.I. Colado A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response Eur J Pharmacol 500 2004 3 13
52. 9-tetrahydrocannabinol in monkeys Psychopharmacologia 37 1974 23 29
53. C. Henquet, L. Krabbendam, J. Spauwen, C. Kaplan, R. Lieb, and H.-U. Wittchen Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people BMJ 330 2005 11 15 10.1136/bmj.38267. 664086.63
54. M. Herkenham, A.B. Lynn, M.D. Little, M.R. Johnson, L.S. Melvin, and B.R. de Costa Cannabinoid receptor localization in brain Proc Natl Acad Sci U S A 87 1990 1932 1936
55. H. Hermann, G. Marsicano, and B. Lutz Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain Neuroscience 109 2002 451 460
56. B. Horan, E.L. Gardner, and C.R. Ashby Jr. Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3, 4-methylenedioxymethamphetamine (MDMA) Synapse 35 2000 160 162
57. A.C. Howlett, C.S. Breivogel, S.R. Childers, S.A. Deadwyler, R.E. Hampson, and L.J. Porrino Cannabinoid physiology and pharmacology: 30 years of progress Neuropharmacology 47 Suppl. 1 2004 345 358
58. Hubner CB, Bird M, Rassnick S, Kornetsky C. The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward. Psychopharmacology 1988;95:49-51.
59. A. Johns Psychiatric effects of cannabis Br J Psychiatry 178 2001 116 122
60. 3H]dopamine release from superfused rat brain slices Eur J Pharmacol 132 1986 269 276
61. 9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys Psychopharmacology 169 2003 135 140
62. J.B. Kamien, C.E. Johanson, C.R. Schuster, and W.L. Woolverton The effects of (+/-)-ethylenedioxy methamphetamine and (+/-)-methylenedioxy amphetamine in monkeys trained to discriminate (+)-amphetamine from saline Drug Alcohol Depend 18 1986 139 147
63. S. Kaymakcalan Physiology and psychological dependence on THC in rhesus monkeys W.D.M. Paton J. Crown Cannabis and its derivatives 1972 University Press Oxford 142 149
64. S. Kaymakcalan Tolerance to and dependence on cannabis Bull Narc 25 1973 39 47
65. H.P. Kruger, and M. Vollrath Effects of cannabis and amphetamines on driving simulator performance of recreational drug users under natural conditions 15th International Conference on Alcohol, Drugs and traffic Safety (T2000), Stockholm, Sweden: May 22nd-26th 2000
66. R.J. Lamb, and R.R. Griffiths Self-injection of d,1-3,4- methylenedioxymethamphetamine (MDMA) in the baboon Psychopharmacology 9 1987 268 272
67. J.R. Leite, and E.A. Carlini Failure to obtain "cannabis directed behavior" and abstinence syndrome in rats chronically treated with cannabis sativa extracts Psychopharmacologia 36 1974 133 145
68. S. Lenton, A. Boys, and K. Norcross Raves, drugs and experience: drug use by a sample of people who attend raves in Western Australia Addiction 92 1997 1327 1337
69. A.A. Li, G.J. Marek, G. Vosmer, and L.S. Seiden Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats Pharmacol Biochem Behav 33 1989 641 648
70. M.E. Liechti, M.R. Saur, A. Gamma, D. Hell, and F.X. Vollenweider Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans Neuropsychopharmacology 23 2000 396 404
71. 9-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys Behav Pharmacol 5 1994 219 225
72. D. Marona-Lewicka, G.S. Rhee, J.E. Sprague, and D.E. Nichols Reinforcing effects of certain serotonin-releasing amphetamine derivatives Pharmacol Biochem Behav 53 1996 99 105
73. U.D. McCann, S.O. Slate, and G.A. Ricaurte Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy') Drug Saf 15 1996 107 115
74. U.D. McCann, V. Eligulashvili, and G.A. Ricaurte (+/-) 3,4-Methylenedioxy methamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies Neuropsychobiology 42 2000 11 16
75. A. Meyer, A. Mayerhofera, K. Kovara, and W.J. Schmidt Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine ('Ecstasy') and 3,4-methylenedioxy-ethylamphetamine ('Eve') measured by conditioned place preference in rats Neurosci Lett 330 2002 280 284
76. K.A. Miczek, and M. Haney Psychomotor stimulant effects of damphetamine, MDMA and PCP: aggressive and schedule-controlled behavior in mice Psychopharmacology 115 1994 358 365
77. R. Milani, J.J.D. Turner, A.C. Parrott, and R. Parmar Recreational drug use and psychobiological problems, collaborative UK/Italy study (5): ecstasy (MDMA) polydrug user findings J Psychopharmacol 14 2000 A15
78. M.J. Morgan Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity Neuropsychopharmacology 19 1998 252 264
79. J. Morland Toxicity of drug abuse-amphetamine designer drugs (ecstasy): mental effects and consequences of single dose use Toxicol Lett 112-113 2000 147 152
80. K.C. Morley, K.M. Li, G.E. Hunt, P.E. Mallet, and I.S. McGregor Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats Neuropharmacology 46 2004 954 965
81. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65
82. R. Nagilla, M.C. Newland, J. Snyder, and M.E. Bronson Effect of once weekly treatment with 3,4-methylenedioxy methamphetamine on schedule-controlled behavior in rats Eur J Pharmacol 358 1998 1 8
83. J.F. Nash Jr., H.Y. Meltzer, and G.A. Gudelsky Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxy methamphetamine J Pharmacol Exp Ther 245 1988 873 879
84. National Drug Strategy Household Survey, 2002. http://www.aihw.gov.au/ publications/phe/ndshs01sts/ndshs01sts.pdf.
85. W.I. Nixdorf, K.B. Burrows, G.A. Gudelsky, and B.K. Yamamoto Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate J Neurochem 77 2001 647 654
86. D. Parolaro, and T. Rubino Is cannabinoid transmission involved in rewarding properties of drugs of abuse? Br J Pharmacol 136 2002 1083 1084
87. A.C. Parrott, E. Sisk, and J.J. Turner Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users Drug Alcohol Depend 60 2000 105 110
88. A.C. Parrott, H. Fox, and R.M. Milani Cannabis, ecstasy/MDMA and memory: a commentary on Simon and Mattick's recent study Addiction 98 2003 1003 1005
89. A. Parrott, E. Gouzoulis-Meyfrank, J. Rodgers, and N. Solowij Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects J Psychopharmacol 18 2004 572 575
90. R. Pickens, T. Thompson, and D.C. Muchow Cannabis and phencyclidine self-administered by animals L. Goldfarb F. Hoffmeister Psychic dependence Bayer-Symposium vol. IV 1973 Springer Berlin 78 86
91. E. Ratzenboeck, A. Saria, N. Kriechbaum, and G. Zernig Reinforcing effects of MDMA ("ecstasy") in drug-naive and cocaine-trained rats Pharmacology 62 2001 138 144
92. L.D. Reid, C.L. Hubbell, J. Tsai, M.D. Fishkin, and C.A. Amendola Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulation Pharmacol Biochem Behav 53 1996 477 480
93. L. Reneman, J. Booij, B. Schmand, W. van den Brink, and B. Gunning Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission Psychopharmacology 148 2000 322 324
94. M. Rizzo, C.T.J. Lamers, N. Skaar, C.W. Sauer, J. Ramaekers, and G.J. Andersen Perception of heading in abstinent MDMA and THC users J Vis 3 2003 410a
95. P. Robledo, G. Balerio, F. Berrendero, and R. Maldonado Study of the behavioural responses related to the potential addictive properties of MDMA in mice Naunyn Schmiedebergs Arch Pharmacol 369 2004 338 349
96. J. Rodgers, T. Buchanan, A.B. Scholey, T.M. Heffernan, J. Ling, and A. Parrott Differential effects of Ecstasy and cannabis on self-reports of memory ability: a web-based study Hum Psychopharmacol 16 2001 619 625
97. 1 receptors in pituitary cells Brain Res 841 1999 114 122
98. J.A. Rosecrans, and R.A. Glennon The effect of MDA and MDMA (ecstasy) isomers in combination with pirenpirone on operant responding in mice Pharmacol Biochem Behav 28 1987 39 42
99. J. Salzmann, C. Marie-Claire, S. Le Guen, B.P. Roques, and F. Noble Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice Br J Pharmacol 140 2003 831 838
100. M.D. Schechter Serotonergic-dopaminergic mediation of 3,4-methylene dioxymethamphetamine (MDMA, "ecstasy") Pharmacol Biochem Behav 31 1988 817 824
101. M.D. Schechter Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination Pharmacol Biochem Behav 38 1991 539 544
102. F. Schifano, L. Di Furia, G. Forza, N. Minicuci, and R. Bricolo MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients Drug Alcohol Depend 52 1998 85 90
103. C.R. Schuster, and C.E. Johanson Relationships between the discriminative stimulus properties and subjective effects of drugs F.C. Colpaert R.L. Balster Transduction mechanisms of drug stimuli 1988 Springer-Verlag Berlin 161 175
104. R. Siliquini, F. Faggiano, S. Geninatti, E. Versino, B. Mitola, and R. Ippolito Patterns of drug use among young men in Piedmont (Italy) Drug Alcohol Depend 64 2001 329 335
105. J. Strote, J.E. Lee, and H. Wechsler Increasing MDMA use among college students: results of a national survey J Adolesc Health 30 2002 64 72
106. G. Tanda, P. Munzar, and S.R. Goldberg Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys Nat Neurosci 3 2000 1073 1074
107. The Good Drugs Guide: http://www.thegooddrugsguide.com/articles/ e_politics.htm.
108. D.M. Thompson, P.J. Winsauer, and J. Mastropaolo Effects of phencyclidine, ketamine and MDMA on complex operant behavior in monkeys Pharmacol Biochem Behav 26 1987 401 405
109. L. Topp, J. Hando, P. Dillon, A. Roche, and N. Solowij Ecstasy use in Australia: patterns of use and associated harm Drug Alcohol Depend 55 1999 105 115
110. J.M. Van Ree, J.L. Slangen, and D. de Wied Intravenous self administration of drugs in rats J Pharmacol Exp Ther 204 1978 547 557
111. T.B. Virden, and L.E. Baker Disruption of the discriminative stimulus effects of S(+)-3,4-methylenedioxymethamphetamine (MDMA) by (+/-)-MDMA neurotoxicity: protection by fluoxetine Behav Pharmacol 10 1999 195 204
112. F.X. Vollenweider, A. Gamma, M. Liechti, and T. Huber Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naive healthy volunteers Neuropsychopharmacology 19 1998 241 251
113. E. Webb, C.H. Ashton, P. Kelly, and F. Kamali Alcohol and drug use in UK university students Lancet 348 1996 922 925
114. E. Webb, C.H. Ashton, P. Kelly, and F. Kamali An update on British medical students' lifestyles Med Educ 32 1998 325 331
115. 9-tetrahydrocannabinol in rat drug discrimination Pharmacol Biochem Behav 64 1999 519 522
116. J.L. Wiley, R.L. Barrett, D.T. Britt, R.L. Balster, and B.R. Martin Discriminative stimulus effects of delta 9-tetrahydrocannabinoland delta 9-11-tetrahydrocannabinol in rats and rhesus monkeys Neuropharmacology 32 1993 359 365
117. 9- tetrahydrocannabinol in rhesus monkeys Drug Alcohol Depend 40 1995 81 86
118. J.L. Wiley, J.A. Lowe, R.L. Balster, and B.R. Martin Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys J Pharmacol Exp Ther 275 1995 1 6
119. A.R. Winstock, P. Griffiths, and D. Stewart Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK Drug Alcohol Depend 64 2001 9 17
120. B.K. Yamamoto, and L.J. Spanos The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat Eur J Pharmacol 148 1988 195 203
121. B.K. Yamamoto, J.F. Nash, and G.A. Gudelsky Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and γ-aminobutyric acid in the substantia nigra J Pharmacol Exp Ther 273 1995 1063 1070